As CCN2 plays roles in connective tissue pathologies, targeting Ets-1 may be beneficial in alleviating pathologies of tissue remodeling and repair, including cancer, arthritis and fibrosis.
These six clinical syndromes are linked to a number of molecular pathologies that target the frontal and temporal lobes, known as the frontotemporal lobar degenerations (FTLDs) [ 48].
In both pathologies, mammalian target of rapamycin (mTOR) pathway activation has been demonstrated [ 3– 6], possibly representing a primary pathogenic mechanism and a potential target for new treatment approaches [ 7].
Several systematic reviews [ 26– 28, 44] and a meta-analysis [ 45] evaluating the impacts of the CCM have demonstrated the effectiveness of this model in a variety of settings, pathologies and target groups.
The range of study populations, severity and types of associated pathology in target age groups means that few of the studies on HPV prevalence are generalizable.
Hence, in 1989 Marc Feldmann recruited Brian Foxwell to the Kennedy Institute of Rheumatology, where rheumatoid arthritis (RA) provided a natural focus for Brian's interest in inflammation, mediators, and eventually cytokine signal transduction mechanisms and their relationships to molecular pathology, drug target identification and the development of new therapies.
This decision problem can be conceptualised as a before and after comparison of two diagnostic strategies – current practice only and current practice with CT and/or MRI (see additional file 3) where CT and MRI are considered reference standards for the pathology investigated (target disorders).
Similar to cancer research, the identification and validation of pathology-associated targets is of fundamental importance to antibody development.
In contrast those with C9ORF72 mutations tended to have more dorsal white matter tract pathology, which targeted the cingulum bundle and corpus callosum.
Despite this close proximity, the LGN did not show evidence of tau propagation (Fig. 3j); however, it is prone to P301SBE-associated tau pathology when targeted by a more ventral infusion coordinate (dural surface: DV −2.80; data not shown).
